CLINICAL_TRIALS
trial_result
· 2024-01-16
Clinical Trial Update: Study of ARO-ANG3 in Adults With Mixed Dyslipidemia [Phase 2]
Summary
Phase 2 study of ARO-ANG3 in adults with mixed dyslipidemia has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Arrowhead Pharmaceuticals | Conditions: Mixed Dyslipidemia | Phase 2 | Status: COMPLETED | Results posted: 2024-01-16